Pill for Skin Disease Also Curbs Excessive Drinking

Apremilast, an FDA-approved drug for the treatment of skin conditions including psoriasis and psoriatic arthritis, triggers increased activity in the nucleus accumbens, a brain area associated with regulating alcohol intake. Apremilast reduced drinking behaviors in mouse models with a genetic risk of alcohol use disorder.

from Neuroscience News https://ift.tt/KUo2D1J